Key result
Diabetes mellitus was independently associated with an 11% increased risk of overall mortality compared to no diabetes in patients hospitalized for acute heart failure.
Why the study?
Although over one-third of acute heart failure patients have diabetes mellitus, it remains unclear whether diabetes has an adverse impact on clinical outcomes.
Does diabetes mellitus increase mortality in patients hospitalized for acute heart failure?
Cohort (n=5,394)
Yes
Does diabetes mellitus increase mortality in patients hospitalized for acute heart failure?
Diabetes mellitus is independently associated with increased long-term mortality in patients hospitalized for acute heart failure, particularly those with reduced ejection fraction, highlighting the importance of adequate glycemic control.
Answers are grounded in this paper and cite their sources.
DM associated with higher acute HF mortality; leaves open whether glycemic control improves prognosis in this population.
BACKGROUND: Although more than one-third of the patients with acute heart failure (AHF) have diabetes mellitus (DM), it is unclear if DM has an adverse impact on clinical outcomes. This study compared the outcomes in patients hospitalized for AHF stratified by DM and left ventricular ejection fraction (LVEF). METHODS: The Korean Acute Heart Failure registry prospectively enrolled and followed 5625 patients from March 2011 to February 2019. The primary endpoints were in-hospital and overall all-cause mortality. We evaluated the impact of DM on these endpoints according to HF subtypes and glycemic control. RESULTS: During a median follow-up of 3.5 years, there were 235 (4.4%) in-hospital mortalities and 2500 (46.3%) overall mortalities. DM was significantly associated with increased overall mortality after adjusting for potential confounders (adjusted hazard ratio [HR] 1.11, 95% confidence interval [CI] 1.03-1.22). In the subgroup analysis, DM was associated with higher a risk of overall mortality in heart failure with reduced ejection fraction (HFrEF) only (adjusted HR 1.14, 95% CI 1.02-1.27). Inadequate glycemic control (HbA1c ≥ 7.0% within 1 year after discharge) was significantly associated with a higher risk of overall mortality compared with adequate glycemic control (HbA1c < 7.0%) (44.0% vs. 36.8%, log-rank p = 0.016). CONCLUSIONS: DM is associated with a higher risk of overall mortality in AHF, especially HFrEF. Well-controlled diabetes (HbA1c < 7.0%) is associated with a lower risk of overall mortality compared to uncontrolled diabetes. Trial registration ClinicalTrial.gov, NCT01389843. Registered July 6, 2011. https://clinicaltrials.gov/ct2/show/NCT01389843.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2020) conducted a cohort in Acute heart failure (n=5,394). Diabetes mellitus vs. No diabetes mellitus was evaluated on Overall all-cause mortality (HR 1.11, 95% CI 1.03-1.22, p=0.013). Diabetes mellitus was independently associated with an 11% increased risk of overall mortality compared to no diabetes in patients hospitalized for acute heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: